Latest Product Innovation News

Perpetual Limited reported a 2.5% increase in assets under management to A$226.8 billion for Q4 FY25, driven by strong market performance and inflows. The company reaffirmed its expense guidance and continues to pursue the sale of its Wealth Management business.

Microba Life Sciences reports strong Q4 FY25 growth driven by record microbiome test sales and clinician adoption in Australia and the UK, while advancing its therapeutics pipeline and targeting regional break-even in FY26.

BetMakers Technology Group capped FY25 with its strongest quarterly results ever, showcasing record profitability, positive cash flow, and a debt-free balance sheet. The company’s strategic investments and recent capital raise set the stage for accelerated growth in FY26, including a key acquisition in Nevada.

Norwood Systems delivered its strongest quarter yet with record cash inflows, significant debt reduction, and expanding global partnerships, setting a robust foundation for FY2026.

Connexion Mobility reported steady revenue growth and a 7% increase in net profit before tax for Q4 FY25, driven by expanding SaaS subscriptions and strategic product enhancements.

Tinybeans Group Limited has reported a second straight quarter of positive operating cash flow alongside steady subscriber growth and new product launches, signaling a turning point for the family-focused subscription platform.

IKE GPS Group Limited has opened a A$2.0 million Share Purchase Plan following an A$18 million placement, aiming to accelerate product innovation and strategic expansion.

Vonex Limited reports operational improvements, low complaint rates, and strategic executive hires in Q4 FY25, alongside a pivotal acquisition agreement with MaxoTel.

HUB24 Limited has reported a record $19.8 billion in net inflows for FY25, driven by strong platform growth and significant migrations from Equity Trustees. The company also launched an innovative high net worth solution, reinforcing its market leadership.

Atturra Limited reports FY25 underlying EBITDA exceeding $31 million and revenue topping $300 million, setting the stage for a strong growth outlook in FY26 driven by acquisitions and product expansion.

ClearVue Technologies initiates a thorough expenditure review and announces a key board resignation as it aims to sharpen its focus on product innovation and global expansion.

Compumedics Limited has reported record sales orders and a return to profitability in FY25, setting the stage for robust growth in FY26 driven by US market traction and SaaS expansion.